Enterprises of all stripes have started to invest heavily in AI to help them understand their customers more deeply and to gain the advantages of superior customer experience (CX). Yet as leaders strive to form a more complete picture of customer preferences and behaviours, they continue to rely on ageing survey-based measurement systems that for decades have formed the backbone of CX efforts.
In the age of VUCA world & Industry 4.0 revolution, AI continues to dominate the business landscape. Whilst the naysayers have advocated the doomsday for humanity by predicting the advent of singularity, AI for good & all have several applications to usher a new change in how we make decisions at enterprise and personal fronts.
Talent Science is the business capability of using advanced data analysis techniques and predictive models to drive HCM decision making. It calls for a logical connection between decisions about people, HR program investments and strategic business outcomes. This can form a backbone of human resource function of all organizations independent of the sector in which it operates. […]
Featured Article Author: Koyelia Ghosh Roy, EXL Copilot is a buzzword now with almost all assistive solutions being tagged with them. However, it is the most in-demand solution in today’s era, helping from simple automation of mundane tasks like O365 CoPilot or very sophisticated, customized solutions for specialized tasks like data analysis using database agents […]
Featured Article Author: Pankaj Zanke, Sapient Legacy systems, which many organizations rely on, often become technological burdens for the same organization. Built with old technologies, tools, and architecture, they need help keeping up with modern business’s latest technological needs. Scaling and integration issues and security issues also affect agility and innovation. However, how they are […]
Featured Article: Author: Vijay Morampudi, Director & Head of AI, Wavelabs Technologies Drug discovery takes 12-15 years and a median investment of nearly $1 billion to bring a new drug to market. While the true cost of research and development may be as high as $2.5 billion per marketed therapy, when factoring in abandoned trials and […]